Collared Earthstar

Metadata

Regulatory Status

China (Traditional Use)

• Traditional Chinese medicine use: G. triplex has documented use in TCM for reducing inflammation in the respiratory tract and for stanching bleeding and reducing swelling. The Chinese name for earthstar mushrooms reflects their folk medicinal reputation.
• Not listed in the Chinese Pharmacopoeia (2020 edition). Use remains at the folk medicine level without official pharmacopoeia recognition.

Indigenous American Traditions

• Cherokee use: The Cherokee placed fruit bodies of earthstar mushrooms on the navels of newborn babies after the umbilical cord was cut, serving both as a prophylactic and therapeutic measure. This practice reflects the traditional hemostatic (styptic) reputation of earthstar fungi.
• Tewa and other traditions: Additional indigenous American uses of earthstar mushrooms have been documented, primarily as wound dressings and hemostatic agents.

Europe

• Not listed in any European pharmacopoeia or herbal medicine monograph. No HMPC, ESCOP, or Commission E assessment.
• Considered inedible due to tough, leathery texture. Not consumed as food.

United States

• Not marketed as a dietary supplement or medicine. No GRAS determination.
• No FDA evaluation for any therapeutic claim.

Japan / Korea

• Not listed in the Japanese or Korean Pharmacopoeias. No significant traditional medicinal use documented in East Asian herbal traditions outside of Chinese folk medicine.

Conditions & Indications

Primary: Hemostatic and Wound Healing (Folk Medicine)

• Traditional styptic use: The dried spore mass (gleba) of earthstar mushrooms has been used as a wound powder to stop bleeding. The fine, powdery spore mass acts as a physical hemostatic agent and may also exert astringent effects. This use is documented across multiple cultural traditions (TCM, Cherokee, other indigenous American peoples).
• Mechanism unclear: Whether the hemostatic effect is purely physical (absorbent powder) or involves bioactive compounds that promote coagulation has not been determined. Research on the related species Geastrum fimbriatum demonstrated anticoagulant activity (activated partial thromboplastin time assay), which appears to contradict the traditional hemostatic claim. This contradiction has not been resolved. [CONTESTED]

Secondary: Respiratory Anti-Inflammatory (TCM)

• Traditional TCM use: G. triplex is used in Chinese folk medicine to reduce inflammation in the respiratory tract, including for sore throats and bronchial complaints. The specific preparation methods and dosages used in TCM folk practice are not well-documented in the English-language literature. [NEEDS-RESEARCH]

Emerging/Preclinical

• Antibacterial activity: Crude extracts of G. triplex have demonstrated relatively high antibacterial activity against both plant and human pathogens in vitro. The active compounds responsible for this activity have not been identified.
• Anti-inflammatory activity (genus level): A study on Geastrum fimbriatum demonstrated 12.92% lipoxygenase inhibition by ethanolic extract, providing preliminary evidence for anti-inflammatory activity within the genus. Whether G. triplex shares this activity has not been tested. [UNCERTAIN]
• Anticoagulant activity (genus level): G. fimbriatum ethanolic extract showed significant anticoagulant effects in the activated partial thromboplastin time (APPT) test evaluating the intrinsic coagulation pathway. This finding is notable and potentially relevant to G. triplex, but also paradoxically contradicts the traditional hemostatic use. [CONTESTED]
• Fungal sterol bioactivity: The identified sterols (ergosta-4,6,8(14),22-tetraen-3-one, peroxyergosterol) are bioactive compounds found in other medicinal fungi. Peroxyergosterol has demonstrated anti-inflammatory and cytotoxic activity in studies of other fungal species. [UNCERTAIN — not tested specifically in G. triplex]
• Polysaccharide immunomodulation (inferred): Beta-glucan and polysaccharide content, detected in chemical analysis, may contribute to immune modulation consistent with general fungal immunology, but this has not been assessed for G. triplex. [NEEDS-RESEARCH]

Mechanism of Action

Primary Mechanisms

1. Physical hemostatic action: The fine, dry spore mass of G. triplex functions as a physical absorbent when applied to wounds, promoting clot formation by concentrating clotting factors and providing a matrix for platelet aggregation. This purely mechanical mechanism requires no specific bioactive compound and is shared with other puffball-like fungi (Lycoperdon, Calvatia species).

2. Fungal sterol pharmacology: The ergosterol derivatives identified in G. triplex — particularly peroxyergosterol and ergosta-4,6,8(14),22-tetraen-3-one — belong to a class of compounds with demonstrated anti-inflammatory and cytotoxic activities in other fungal species. Peroxyergosterol inhibits NF-kB activation and suppresses pro-inflammatory cytokine production. Whether these compounds are present at pharmacologically relevant concentrations in G. triplex preparations has not been determined.

3. Antibacterial mechanisms (uncharacterized): The antibacterial activity of G. triplex crude extracts against plant and human pathogens has been demonstrated but the specific active compounds and mechanisms have not been identified. Potential antimicrobial agents include phenolic compounds, sterols, and terpenoids.

Secondary Mechanisms

• Beta-glucan immunomodulation (inferred): Polysaccharides in the cell wall and extracellular matrix may engage Dectin-1 and complement receptor 3 (CR3) on innate immune cells, stimulating macrophage activation, cytokine production, and phagocytic activity. This is a well-established mechanism for basidiomycete fungi generally but unproven for G. triplex. [UNCERTAIN]
• Lipoxygenase inhibition (genus level): The anti-inflammatory effect demonstrated for G. fimbriatum via lipoxygenase inhibition suggests a possible mechanism for the traditional respiratory anti-inflammatory use of earthstar mushrooms. Lipoxygenase inhibition reduces leukotriene synthesis, which mediates airway inflammation.

Clinical Evidence Summary

No human clinical trials, animal studies, or case reports have been published for Geastrum triplex. The evidence base consists of folk medicine documentation, chemical characterization, and a single in vitro antibacterial study for G. triplex, supplemented by one in vitro study on the related species G. fimbriatum.

Key Studies

Evidence Limitations

• No human clinical trials or animal studies exist for any Geastrum species.
• The traditional hemostatic use may be purely physical (spore powder as absorbent) rather than pharmacological.
• The anticoagulant activity found in G. fimbriatum appears to contradict the traditional hemostatic use, creating an unresolved paradox. The hemostatic effect may be topical/physical while anticoagulant effects are systemic/extract-based.
• Antibacterial activity was demonstrated with crude extracts; no bioactivity-guided fractionation or compound identification has been performed for G. triplex.
• The polyphyly of G. triplex sensu lato means that specimens identified under this name may belong to different, genetically distinct species, complicating the interpretation of any chemical or biological data.
• The “schizostatin” compound sometimes associated with Geastrum species in popular sources actually originates from Schizophyllum commune, not from Geastrum species. No evidence supports the presence of schizostatin in G. triplex. [Note: this corrects a common misattribution]
• Chemical studies have identified the compounds present but have not assessed their bioactivity in the context of G. triplex.

Safety Profile

General Assessment

Geastrum triplex is considered inedible due to its tough, leathery texture and is not consumed as food in any culinary tradition. Traditional medicinal use has involved topical application of dried spore powder to wounds and occasional internal use (decoctions for respiratory complaints in TCM). No adverse effects from traditional use have been documented, but formal safety assessment has not been conducted.

Contraindications

• Pregnancy and lactation: Insufficient safety data.
• Spore allergy: The dried spore mass, which is the traditional medicinal part, may trigger allergic reactions in individuals sensitive to fungal spores. Inhalation of large quantities of any puffball spore mass can cause lycoperdonosis, a respiratory condition.
• Not for internal use without guidance: Internal consumption of G. triplex decoctions should only be undertaken under the guidance of a qualified traditional medicine practitioner.

Drug Interactions

• No documented drug interactions. Given the preliminary evidence for anticoagulant activity in related Geastrum species, a theoretical interaction with anticoagulant medications (warfarin, heparin) cannot be excluded if consumed internally, though clinical significance has not been assessed. [UNCERTAIN]

Side Effects

• Lycoperdonosis risk: Inhalation of large quantities of spore powder from any puffball or earthstar can cause lycoperdonosis, a granulomatous pneumonitis characterized by cough, dyspnea, and pulmonary infiltrates. This is rare and associated with deliberate inhalation or extremely high spore exposure.
• No other documented side effects from traditional topical or internal use.

Toxicology

• No known toxins have been identified in G. triplex.
• No formal toxicological studies (LD50, subchronic, chronic) have been published.
• Spore safety: Topical application of dried spore powder to wounds has a long traditional safety record across multiple cultures.

Clinical Dosage

Traditional Topical Use (Wound Powder)

• Preparation: Dried, mature fruiting bodies collected after the spore mass has developed. The gleba (inner spore mass) is removed and dried to a fine powder.
• Application: Applied directly to wounds as a hemostatic and protective covering.
• No standardized dose — applied as needed to cover the wound surface.

Traditional Internal Use (TCM Decoction)

• No standardized dosage documented in English-language literature.
• Traditional preparation: Presumed to involve decoction of dried fruiting body material, consistent with general TCM practice for fungal medicines. [NEEDS-RESEARCH]

No Modern Supplement Dosage

No supplement or extract products exist. No dose-finding studies have been conducted.

Sources

• Gupta VK, Agrawal M, Sharma R. Antibacterial potential of Geastrum triplex jungh. against plant and human pathogens. Int J Pharm Sci Res. 2015;6(9):3826-3830
• Sadi G, Kaya A, Yalcin HA, et al. In vitro anticoagulant and antiinflammatory activities of Geastrum fimbriatum Fr., namely as Earthstar fungus. Int J Second Metab. 2019;6(1):65-71
• Kasuya T, Hosaka K, Uno K, Kakishima M. Phylogenetic placement of Geastrum melanocephalum and polyphyly of Geastrum triplex. Mycoscience. 2012;53(6):411-426
• Junghuhn FW. Praemissa in floram cryptogamicam Javae insulae. Batavia. 1840
• Moser M. In: Agarics and Boleti: Keys to the European Species. English version, 5th ed. 2001
• Native American Museum Blog. Medicinal Monday — the “Star” of the Show — Earth Stars. 2021
• Ultimate Mushroom. Geastrum triplex: The Ultimate Mushroom Guide. Available at: ultimate-mushroom.com
• Zombiemyco. Earthstar Fungus (Geastrum triplex). Available at: zombiemyco.com
• Macquarie University. Fungi of the Month: Geastrum triplex — Collared Earthstars. Available at: mq.edu.au

Connections

• Puffball medicinal relatives: G. triplex shares the traditional hemostatic (wound powder) use with Calvatia gigantea (giant puffball), which also has a long history of topical application as a styptic agent. The physical mechanism of spore powder hemostasis is common to all gasteromycetes with powdery spore masses.
• Schizophyllum commune connection: The squalene synthase inhibitor schizostatin — sometimes mistakenly attributed to Geastrum — is actually produced by Schizophyllum commune. This distinction is important for accurate pharmacological attribution.
• Polypore anti-inflammatory comparison: The respiratory anti-inflammatory use of G. triplex in TCM parallels similar traditional applications of Fomes fomentarius (tinder fungus) in European folk medicine. Both are tough, non-edible fungi with traditional topical and internal medicinal applications, though their chemical profiles differ substantially.
• Fungal immunomodulatory potential: The polysaccharide content of G. triplex places it within the broader context of fungal immunomodulation research exemplified by Turkey Tail (Trametes versicolor) and Reishi (Ganoderma lucidum). However, unlike these well-studied species, G. triplex has no clinical evidence supporting immune modulation, and any claims remain entirely theoretical.
• Gasteromycete medicine: Earthstars, puffballs, and bird’s nest fungi represent an underexplored group of basidiomycetes with traditional medicinal uses across multiple cultures but very limited modern scientific investigation. G. triplex is representative of this gap between ethnomycological knowledge and contemporary pharmacological validation.